Research and Development

Showing 15 posts of 9599 posts found.

Shire withdraws ADHD patch filing

March 19, 2009 Research and Development, Sales and Marketing Shire

Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …

Sanofi boosted by Multaq vote of approval

March 19, 2009 Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US

An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …

FDA to review Xarelto safety concerns

March 19, 2009 Research and Development, Sales and Marketing Xarelto

Anti-blood clotting drug Xarelto could fail to win approval in the US due to safety concerns. The FDA has convened …

Biosimilars bill offers 12 years’ marketing exclusivity

March 19, 2009 Research and Development US, generics

The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …

Hamburg appointed as new FDA head

March 18, 2009 Research and Development FDA

A leading public health expert has been appointed as the new head of the FDA. President Obama has selected Dr …

Patent office shows tougher stance on “evergreening”

March 18, 2009 Research and Development Europe

The rate of patent applications refused in Europe has risen to an all time high, as authorities target "evergreening" of …

Getting the most out of your product portfolio

March 17, 2009 Research and Development, Sales and Marketing portfolio, product

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

One in five European biotech companies facing bankruptcy

March 17, 2009 Research and Development biotech

Around one in five European biotech companies could go bust by the end of 2009 if new funding doesn't emerge …

Blow for Genzyme as FDA finds fault with Allston facility

March 13, 2009 Research and Development, Sales and Marketing FDA, Genzyme

The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …

Working Life: Andrew Clark

March 13, 2009 Research and Development, Sales and Marketing UCB, library

How did you find your way into your current role? On return from a working holiday to New Zealand I …

Government picks top-level NHS-academic research centres

March 12, 2009 Research and Development Academic

Five establishments have been named by the government as Academic Health Science Centres (AHSCs). The centres – UCL Partners, Cambridge …

Obama ends stem cell funding ban

March 10, 2009 Research and Development US, stem cell

President Obama has lifted the US ban on federal funding for new stem cell research, signalling another marked departure in …

Are biosimilars delivering the goods in the EU?

March 10, 2009 Manufacturing and Production, Research and Development biosimilars

In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …

UK’s Stem Cell Sciences acquired by US company

March 5, 2009 Research and Development Stem cells

US company StemCells Inc is to expand its capabilities in the field with the purchase of UK based Stem Cell …
The Gateway to Local Adoption Series

Latest content